MedPath

Ketorolac Tromethamine

These highlights do not include all the information needed to use KETOROLAC TROMETHAMINE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for KETOROLAC TROMETHAMINE OPHTHALMIC SOLUTION. KETOROLAC TROMETHAMINE ophthalmic solution 0.5% Initial U.S. Approval: 1991

Approved
Approval ID

007a4da5-d794-416c-94b3-6ee9e7842c52

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 27, 2021

Manufacturers
FDA

Aurobindo Pharma Limited

DUNS: 650082092

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ketorolac Tromethamine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code65862-770
Application NumberANDA205190
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ketorolac Tromethamine
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateDecember 27, 2021
FDA Product Classification

INGREDIENTS (8)

EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
KETOROLAC TROMETHAMINEActive
Quantity: 5 mg in 1 mL
Code: 4EVE5946BQ
Classification: ACTIB
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
OCTOXYNOL-40Inactive
Code: 9T1C662FKS
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ketorolac Tromethamine - FDA Drug Approval Details